![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/IPCALAB.png)
Share the post "IPCA LABORATORIES ‘s Q3 2024-25 Latest News: Revenue Up by 10.34% Year-on-Year"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 10.34 % in the past year, decrease in net sales/revenue by -8.19 %. 🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 3.08 %. Marginal increase in other income during this quarter, up by 2.41%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for IPCA LABORATORIES LTD.. Notable increase of 95.38 % in net profit Year to Year, IPCA LABORATORIES LTD.’s profitability increased by 9.6 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 95.37 % Year to Year. EPS increased by 9.67 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1506.83 Cr | Rs. 1810.94 Cr | Rs. 1662.68 Cr | -8.19 % | + 10.34 % |
| Expenses | Rs. 1233.34 Cr | Rs. 1408.83 Cr | Rs. 1251.59 Cr | -11.16 % | + 1.48 % |
| Operating Profit | Rs. 273.49 Cr | Rs. 402.11 Cr | Rs. 411.09 Cr | + 2.23 % | + 50.31 % |
| OPM % | 18.15 % | 22.2 % | 24.72 % | + 2.52 % | + 6.57 % |
| Other Income | Rs. 16.89 Cr | Rs. 17 Cr | Rs. 17.41 Cr | + 2.41 % | + 3.08 % |
| Interest | Rs. 27.21 Cr | Rs. 17.25 Cr | Rs. 10.17 Cr | -41.04 % | -62.62 % |
| Depreciation | Rs. 63.02 Cr | Rs. 62.65 Cr | Rs. 62.81 Cr | + 0.26 % | -0.33 % |
| Profit before tax | Rs. 200.15 Cr | Rs. 339.21 Cr | Rs. 355.52 Cr | + 4.81 % | + 77.63 % |
| Tax % | 31.58 % | 28.03 % | 24.74 % | -3.29 % | -6.84 % |
| Net Profit | Rs. 136.94 Cr | Rs. 244.12 Cr | Rs. 267.56 Cr | + 9.6 % | + 95.38 % |
| EPS in Rs | Rs. 5.4 | Rs. 9.62 | Rs. 10.55 | + 9.67 % | + 95.37 % |
Today, we’re looking at IPCA LABORATORIES LTD.’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 10.34 %. However, it did see a marginal slip of -8.19 % from the previous quarter. Expenses decreased slightly by -11.16 % quarter-on-quarter, aligning with the annual rise of 1.48 %. Operating profit, while up 50.31 % compared to last year, faced a quarter-on-quarter increase of 2.23 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 6.57 %, but an expansion of 2.52 % sequentially. Other income rose by 2.41 % compared to the last quarter, despite an annual growth of 3.08 %. Interest expenses dropped significantly by -41.04 % from the previous quarter, yet the year-over-year decrease remains at a moderate -62.62 %. Depreciation costs climbed by 0.26 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -0.33 %. Profit before tax grew annually by 77.63 % but saw an increase from the preceding quarter by 4.81 %.
Tax expenses as a percentage of profits decreased slightly by -6.84 % compared to last year, with a more notable quarter-on-quarter decrease of -3.29 %. Net profit rose by 95.38 % year-on-year but experienced a 9.6 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 95.37 % but a quarterly rise of 9.67 %. In summary, IPCA LABORATORIES LTD.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1506.83 Cr | Rs. 1810.94 Cr | Rs. 1662.68 Cr | -8.19 % | + 10.34 % |
| Expenses | Rs. 1233.34 Cr | Rs. 1408.83 Cr | Rs. 1251.59 Cr | -11.16 % | + 1.48 % |
| Operating Profit | Rs. 273.49 Cr | Rs. 402.11 Cr | Rs. 411.09 Cr | + 2.23 % | + 50.31 % |
| Net Profit | Rs. 136.94 Cr | Rs. 244.12 Cr | Rs. 267.56 Cr | + 9.6 % | + 95.38 % |
| EPS in Rs | Rs. 5.4 | Rs. 9.62 | Rs. 10.55 | + 9.67 % | + 95.37 % |
In reviewing IPCA LABORATORIES LTD.’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 10.34 % year-on-year growth, although there was a slight dip of -8.19 % from the previous quarter. Expenses rose by 1.48 % compared to the previous year, with a decrease of -11.16 % quarter-on-quarter. Operating Profit surged by 50.31 % annually, and saw a 2.23 % increase from the last quarter.
Net Profit showed yearly increase of 95.38 %, and experienced a 9.6 % increase from the previous quarter. Earnings Per Share (EPS) rose by 95.37 % annually, however rose by 9.67 % compared to the last quarter. In essence, while IPCA LABORATORIES LTD. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SMFIL.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/RAJESHEXPO.png)
 ltd. logo1.jpg){kind=logo}